Axa S.A. Corcept Therapeutics Inc Transaction History

Axa S.A.

$33.1 Billion
Q2 2024

A detailed history of Axa S.A. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Axa S.A. holds 12,948 shares of CORT stock, worth $568,805. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,948

Previous 22,622 42.76%

Holding current value

$568,805

Previous $569,000 26.19%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $214,859 - $333,559	-9,674 Reduced 42.76%	12,948 $420,000
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $477,324 - $621,200	22,622 New	22,622 $569,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $718,200 - $1.08 Million	36,000 Added 140.08%	61,700 $1.25 Million
Q3 2022 Feb 14, 2023	SELL	$24.7 - $29.12 $960,212 - $1.13 Million	-38,875 Reduced 60.2%	25,700 $658,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $960,212 - $1.13 Million	-38,875 Reduced 60.2%	25,700 $659,000
Q2 2022 Feb 14, 2023	BUY	$17.33 - $25.3 $604,383 - $882,337	34,875 Added 117.42%	64,575 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $604,383 - $882,337	34,875 Added 117.42%	64,575 $1.54 Million
Q1 2022 Feb 14, 2023	BUY	$16.53 - $25.21 $66,120 - $100,840	4,000 Added 15.56%	29,700 $668,000
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $490,941 - $748,737	29,700 New	29,700 $669,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $261,744 - $299,649	-13,300 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$12.27 - $15.65 $42,945 - $54,775	-3,500 Reduced 20.83%	13,300 $186,000
Q2 2018 Aug 13, 2018	SELL	$15.3 - $19.69 $58,140 - $74,822	-3,800 Reduced 18.45%	16,800 $264,000
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $300,554 - $525,300	20,600 New	20,600 $339,000

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.71B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account